Servier Finland
Pharmaceutical company marketing oncology and cardiovascular medicines in Finland and the Nordic region
Highlights
- New on EvolcAdded 2026-10-29
About Servier Finland
Servier Finland Oy is the Finnish subsidiary of the Servier group, a French pharmaceutical company. It sells prescription medicines in the oncology and cardiovascular areas. Listed products include ivabradine, ivosidenib, vorasidenib, trifluridine/tipiracil, pegaspargase, perindopril arginine (Coversyl), indapamide and trimetazidine.
The company operates under the Servier Nordics brand. The group reports investing more than 20% of its Servier-medicine revenue in research and development each year and cites more than 70 scientific collaborations in 2024/2025.
The Finnish entity is registered in Vantaa and was founded in 2001. The Servier group has about 20,000 employees in 130 countries and produces 96.5% of the active ingredients used in its group branded medicines in France. The pages are published in Finnish and Danish.
Product: Prescription pharmaceuticals in oncology and cardiovascular therapy areas, including ivabradine, ivosidenib, vorasidenib, trifluridine/tipiracil, pegaspargase and perindopril arginine.
Public tenders won
2 tenders won since 1 Jan 2024 from 2 public buyers in Finland, worth €130.0M as awarded. From EU award notices (TED) that name Servier Finland by its registry number.
Jobs at Servier Finland
More biotech & pharma companies
SpringDNA
Environmental DNA sampling and laboratory analysis for biodiversity monitoring and impact assessmentsYoung companyNew on EvolcStemSight
Develops stem-cell therapies for corneal blindness for patients with unmet medical needsNew on EvolcSuomen Lääkekehityskeskus
State-owned Finnish company that helps university researchers take drug compounds from early discovery to clinical studiesYoung companyNew on EvolcSwitchPoint Bio
Epigenomics and AI platform for biopharma and clinical research teams developing biomarkers and stratifying patientsYoung companyNew on EvolcSymeres Finland
Preclinical ADME-Tox research services for pharmaceutical and biotechnology companiesNew on EvolcSynbio Powerlabs
Bioprocess research and pilot-scale fermentation services for biotechnology companiesYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- PHP
- WordPress
- jQuery